Burn Cream
Product Images NDC 69396-146

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Burn Cream (NDC 69396-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trifecta Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

R519-539 Globe First Aid Burn Cream 0.9g 10ct 112823 Cder (R519 539 Globe First Aid Burn Cream 0.9g 10ct 112823 Cder)

R519-539 Globe First Aid Burn Cream 0.9g 10ct 112823 Cder (R519 539 Globe First Aid Burn Cream 0.9g 10ct 112823 Cder)
The text is related to a drug product, specifically a burn cream. The cream contains active ingredients such as Benzalkonium Chloride and Lidocaine HCI, aimed at providing temporary relief of pain associated with minor cuts, scrapes, and burns. It also helps protect against harmful bacteria. The instructions advise applying a small amount not more than 3 times daily and may be covered with a sterile bandage. The cream should be stored in a cool, dry area and out of reach of children. Inactive ingredients include Aloe barbadensis leaf juice, Cetearyl alcohol, and others. The product is distributed by Trifecta Pharmaceuticals USA and further assistance can be obtained by calling the provided phone number.*
FDA Label Image

R519-541 Globe First Aid Burn Cream 0.9g 25pk 112823 Cder (R519 541 Globe First Aid Burn Cream 0.9g 25pk 112823 Cder)

R519-541 Globe First Aid Burn Cream 0.9g 25pk 112823 Cder (R519 541 Globe First Aid Burn Cream 0.9g 25pk 112823 Cder)
This text provides detailed information about a topical burn relief product in individual packets, each containing 0.9g of burn cream. The burn cream contains active ingredients such as Benzalkonium Chloride (0.13%) and Lidocaine HCI (0.5%). It is indicated for temporary relief of pain associated with minor cuts, scrapes, and burns while also helping protect against harmful bacteria. The product comes with directions for use, warnings, and a list of inactive ingredients. It is distributed by Trifecta Pharmaceuticals USA and includes contact information for further inquiries.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.